Introduction
T he number of people who require medical intervention to solve bone-related illnesses such as nonunion fractures or loss of bone tissue caused by cancer tends to grow as a result of the constant aging of population. [1] [2] [3] Currently, the gold-standard strategies to address issues like critical bone defects involve the use of autologous bone graft, allografts, and materials like ceramics and metals. 1, 3, 4 All of these strategies have significant problems (e.g., scarce availability of tissues, donor-site morbidity issues, immunogenicity problems, and lack of integration in the host tissue) that limit their application range and their overall performance. 1, 5 It has been accepted for a few years that new strategies are needed to address the challenges posed in this field. Tissue engineering (TE)-based strategies have been trying to solve many of the above-referred problems. These approaches typically involve the use of different cell types suitable for bone TE, growth factors, and 3D biodegradable scaffolds. 4, 6 Such approaches, however, face in many cases serious problems such as inadequate biodegradability rate and the lack of vascularization, which leads to cell necrosis in the bulk of the construct. 2, [7] [8] [9] [10] Cell sheet (CS) engineering technique using thermoresponsive dishes might constitute a useful alternative to solve some of the mentioned issues. This technique, as proposed by Professor Okano's group, allows for the recovery of the cells within its own matrix to be used as intact single, or multilayered, CSs to engineer transplantable tissues. [11] [12] [13] So far this technology was proposed for the treatment of several tissues such as cornea, 14 myocardium, 15 periodontal ligament, 16 and bladder, 17 but never for bone. The peculiar mechanical and biological properties of bone tissue make the translation of the obtained outcomes from the regeneration of the above-mentioned tissues into bone, rather complicated. Others have previously attempted to produce CSs for the regeneration of bone tissue. [18] [19] [20] Zhou et al. 20 wrapped osteogenic CSs made form porcine bone marrow stromal cells around polycaprolactone-calcium phosphate scaffolds. The postsubcutaneous implantation analysis of the construct showed some degree of new bone formation but mainly at the periphery of the scaffolds. The same pattern, around the scaffold, of new calcified tissue was achieved by Gao et al. 19 using a coral scaffold, and by Akahane et al. 18 using a hydroxyapatite ceramic scaffold. In the latter case, 18 the CSs were also ectopically implanted without any scaffold, and 1 new bone formation, though disorganized, was verified. The common outcomes of those three approaches were the formation of new bone tissue fairly disorganized, poorly vascularized, and limited to the surface of the scaffolds on where the CSs were wrapped. In contrast with the abovereferred works, where cells were detached using a cell scraper, the use of thermoresponsive dishes allows for the use of an intact cell-cell and cell-matrix architecture, due to the well-developed culture dish recovery method. 12, 13 In this work, we aimed at studying the in vivo bone formation potential of osteogenic CSs noninvasively recovered by temperature decrease. Osteogenic CSs were created from rat bone marrow stromal cells, cultured in thermoresponsive dishes, and then characterized. The developed sheets were subsequently transplanted subcutaneously to the dorsal flap of nude mice. Implants were recovered at different time points post-transplantation and characterized. New bone formation was apparent from 7 days postimplantation. Six weeks after implantation thick, newly vascularized bone with what appears to be bone marrow was clearly observed.
Materials and Methods

Temperature-responsive culture surfaces
Thermoresponsive dishes (CellSeed) were prepared as previously described 21 Briefly, N-isopropylacrylamide monomer in 2-propanol solution was spread onto 35-mmdiameter culture dishes (BD Biosciences). Dishes were then irradiated by electron beam, resulting in both polymerization and covalent grafting of the poly(N-isopropylacrylamide) (PIPAAm) onto the cell culture surfaces. PIPAAm-grafted dishes were rinsed with cold-distilled water to remove ungrafted monomer, and dried in nitrogen gas. Dishes were finally sterilized with ethylene oxide gas before experimental use.
CS fabrication
Bone marrow was flushed from the femurs of 4-week-old male Wistar rats (Charles River Japan). After vigorous pipetting to disaggregate any clumps, the suspension was placed over Histopaque 1083 (Sigma-Aldrich) and centrifuged at 2500 rpm for 25 min. The mononuclear cell fraction was recovered after centrifugation and washed in phosphate-buffered saline (Sigma-Aldrich) to remove any remaining Histopaque. Cells were then seeded in 100-mmdiameter tissue culture polystyrene dishes and cultured in basal medium ( AU2 c low-glucose DMEM; Wako Pure Chemical Industries), supplemented with 10% fetal bovine serum ( Japan Bioserum Co. Ltd.) and 100 units/mL of penicillinstreptomycin (Sigma-Aldrich Japan) at 37°C and in a 5% of CO 2 humidified atmosphere. After 24 h of culture, nonadherent cells were removed from the culture and the adherent cells were then cultured until semiconfluence was achieved. Cells were detached using a 0.25% trypsin-EDTA solution (Gibco BRL LifeTechnologies) and seeded in 35 mm of diameter thermoresponsive dishes at a concentration of 2. 
Recovery of cells from thermoresponsive dishes
To recover the cells from the thermoresponsive dishes, the culture medium was removed from the culture dishes and replaced with 1 mL of phosphate-buffered saline. A poly(vinylidene difluoride) (PVDF) (Immobilon-P, DUR-APORE Ò ; Millipore Corporation) membrane with a diameter of 20 cm was placed over the cells in the thermoresponsive dishes and incubated at 20°C for 10 min. After this time, CSs spontaneously detached from thermoresponsive dishes. Some of the recovered CSs were fixed in 10% formalin (Wako Pure Chemicals) for posterior histological characterization.
In vivo transplantation
The transplantation of the CSs was carried out as reported previously. 22 Briefly, 6-week-old male nude mice (Charles River Japan) (six animals per transplantation time) were anesthetized with a constant flux of 4% of isofluorane. Dorsal skin was cut opened using 3 · 3 cm cutting sides. Recovered CSs were placed on mouse subcutaneous dorsal flap and left to adhere to the connective tissue of dorsal skin for 5 min. After that time, the PVDF membranes were peeled off from the adhered CSs and silicone membranes were placed over the CSs to prevent the contact between the CSs and the muscular tissue. Control mice (three animals per transplantation time) were also prepared by implanting only silicone membranes. Skin incisions were closed using 5-0 nylon sutures. Animals were kept with food and water ad libitum. After 7 days, 3 weeks and 6 weeks of transplantation, animals were euthanized with CO 2 and implants were recovered for histological characterization.
Histological characterization
After fixation, both in vitro recovered CS and implanted samples were embedded in paraffin, without demineralization, and 5-mm-thick sections were made. Hematoxylin and eosin staining was performed following standard protocols.
To assess mineral deposition alizarin red staining was performed. Briefly, a solution of 0.1% of alizarin red (Sigma-Aldrich) was made in ddH 2 O and the pH was adjusted to 4.6. Sections were deparaffinized and 1 mL of alizarin red solution was added to each slide. Sections were observed in the microscope until correct amount of color developed. Following that, slides were dipped three times in hematoxylin, washed thoroughly in water, de-hydrated, washed in xylene, and mounted with the mounting medium. Pink/purple color was considered positive for mineral deposition. Micrographs of the sections were taken after both stainings.
Immunostaining for osteocalcin was performed by incubating both the CS after in vitro culture and the implant sections with a 1/200 anti-osteocalcin antibody (Millipore Corporation) overnight, at 4°C, and then for 1 h, room temperature, with a biotinylated secondary antibody (Dako Cytomation). Sections were incubated with streptavidinhorseradish peroxidase (DakoCytomation) solution for 20 min and then treated with b AU2 DAB chromogenic substrate solution (DakoCytomation) for 3 min.
Stained sections were analyzed with an Eclipse E800 microscope (Nikon).
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Microcomputed tomography
To investigate the 3D structure of the mineralized tissue formed after transplantation, nondestructive techniques, X-ray and microcomputed tomography (m-CT) (SkyScan), were used. Recovered implants, after paraffin embedding, were cut in half and scanned in a high-resolution mode of 11.32 mm x/y/z and an exposure time of 1900 ms. The energy of the scanner used was 50 keV with a 171 mA current. The m-CT scans were followed by a 3D reconstruction of serial images and quantification of the mineralized tissue using a minimum threshold value of 70.
Calcium quantification
The samples analyzed by m-CT were used for calcium quantification. Therefore, the halves of the recovered implants were weighted and incubated in HCl 0.5 M to remove and dissolve the calcium. Calcium quantification in the obtained solutions was performed using the o-cresolphtaleincomplexon method with the Roche Cobas kit (Roche Diagnostics) following manufacturer's instructions. The absorbance of the samples was read at 570 nm in a microplate reader Synergy-HT (Bio-Tek). The calcium concentrations were extrapolated from the calibration curve obtained using serial dilutions of a calcium chloride solution and then normalized using the initial tissue mass.
Statistical analysis
Data were obtained from three separate experiments with three replicates for each condition and averaged. Standard deviation is reported as a measure of sample deviation. Statistical analysis of the calcium quantification and volume of mineralized tissue was performed using Student's t-test for n = 3 and values were considered statistically significant for p £ 0.05.
Results
Osteogenic CS characterization
The herein used CS engineering methodology allowed fabricating and recovering intact rat bone marrow-derived CSs composed by a dense collagenous matrix where cells are embedded ( F1 c Fig. 1A) . By the same micrograph observations, the estimated thickness of the CSs after recovery was of about 30 mm (Fig. 1A) .
Alizarin red staining was used to confirm the presence of calcium deposition and matrix mineralization in the cultured CSs (Fig. 1B) . Significant calcium deposition in the cultured CSs was observed as evidenced by the intensity of the staining. Immunohistochemistry against osteocalcin showed high positivity for this protein especially in the CS matrix (Fig. 1C) , confirming the osteogenic nature of the cultured and recovered CSs after temperature decrease.
In vivo bone formation after CS transplantation
Evidences of in vivo new bone formation after transplantation of the osteogenic CSs were confirmed by X-ray and m-CT analysis ( F2 c Fig. 2 ). After 7 days of transplantation the amount of dense tissue was already significant and a notorious increase in the density of the neo-bone was observed as the transplantation time increases.
FIG. 1.
In vitro cultured cell sheets after low-temperature recovery from thermoresponsive dishes characterized using (A) hematoxylin and eosin staining, (B) alizarin red staining (mineral deposition in purple), and (C) immunocytochemistry for osteocalcin (expression in brown). Asterisks mark the basal side of the cell sheets. Color images available online at www.liebertonline.com/ten.
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FIG. 2. Representative X-ray (A, D, G) and microcomputed tomography images (side [C, F, I] and front view [B, E, H])
of the transplants (each divided in half after recovery) after (A-C) 7 days, (D-F) 3 weeks, and (G-I) 6 weeks of implantation. Bars in the X-ray images represent 2 mm and are valid for all the images.
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m-CT analysis was also employed to quantify the volume of the mineralized new tissue ( F3 c Fig. 3) . Results showed an increment in volume from *1 mm 3 for day 7 of implantation to 2.7 for the 6th week of implantation. This evolution in the quantity of new mineralized tissue was confirmed by calcium quantification (Fig. 3) using the o-cresolphtalein-complexon method. The detected amount of calcium per mg of tissue increased from 0.005 mg to 0.0157 mg and finally to 0.037 mg, respectively, at 7 days, 3 weeks, and 6 weeks postimplantation.
Alizarin red/hematoxylin and eosin staining of the in vivo samples allowed to observe mineralized tissue at the implant site just 7 days post-transplantation ( F4 c Fig. 4A ). The amount of new bone mineralized increased throughout the time of transplantation until it reached a maximum at 6 weeks posttransplantation (Fig. 4A-D) . The new bone developed in what appears to be separated patches along the width of the subcutaneous dorsal flap. Six weeks after transplantation, numerous contiguous bone patches, with a maximum thickness of 250 mm and a maximum width of 1 mm (Fig. 4C) , were clearly observed. The patches contained a cellular marrow where numerous cells could be found, among which red blood cells (Fig. 4D) . A detailed observation (Fig. 4E) permitted to identify osteocytes embedded in the sectioned mineralized tissue. Moreover, osteoid deposition was evident in some of the sections analyzed (Fig. 4F) .
The immunohistochemistry results for osteocalcin showed that this protein was expressed at different locations even after only 7 days of transplantation ( F5 c Fig. 5A ). These positive sites seem to correlate to sites where new bone was being formed. With the increase of new bone formed with the transplantation time, it was clear that the majority of the cells that were positive for this protein were concentrated around the new tissue (Figs. 5B, C) .
Discussion
The obtained CSs had the expected characteristics after osteogenic differentiation: collagen-rich, thick ECM with abounding mineralized areas. After exposure to a temperature below the lower critical solution temperature, the sheets slightly contracted, as described for other CSs, 23 due to contractile cytoskeleton forces. This means that the thickness of the CSs after detachment, as determined by histological analysis, was greater than when cells were attached, either to the surface or to the PVDF membrane. The presence of what appeared to be mineral deposits was clearly macroscopically identified in the sheets before its recovery from the thermoresponsive dishes. In fact, after the recovery of the CSs from the dishes, several mineral nodules were attached to the dish (data not shown), which was expected to happen considering the protocol used for the osteogenic differentiation. Further, osteocalcin, a noncollagenous matrix protein whose secretion correlates with matrix mineralization being therefore a marker for the osteogenic phenotype, [24] [25] [26] was detected in high amount confirming the osteogenic nature of the developed CSs (Fig. 1B) .
The transplantation of the fabricated CSs to the dorsal flap of nude mice resulted in the formation of bone mineralized tissue, whose volume greatly increased with time. These results also correlated with the amount of calcium quantified at each time point and with the strong staining for osteocalcin, which is an expected outcome because this protein is directly related to matrix mineralization and consequently to new bone formation. [24] [25] [26] Histology results suggest that newly formed tissue organized in patches throughout the flap. By crossing theses results with the m-CT 3D reconstruction, we could conclude that the observed patches were ramifications of the same bone mass. These bone masses had a flat form that may result from the original form of the CSs and/or from the local mechanical environment present in the mouse's subcutaneous site of transplantation, which determined the form of the new tissue. 27, 28 Osteoid formation was also visible in the in vivo histology results. As demonstrated before, 29 ectopic bone formation by transplanted osteogenic cells is initiated by the deposition of osteoid. Osteoid is a partially mineralized immature bone that is eventually fully mineralized by osteogenic cells, thus becoming mature bone. Histological analysis demonstrated the presence of this immature bone proving that bone formation induced by the osteogenic CSs followed the accepted path of ectopic bone formation. 29 Moreover, the newly 
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formed tissue presented a marrow space where multiple cells were observed. Erythrocytes were detected in that marrow, which might indicate the existence of erythropoiesis or the vascularization of that tissue. These observations and in particular the proven existence of a direct connection between vasculature and bone remodeling [30] [31] [32] [33] [34] reinforce the hypothesis that the newly formed bone was being remodeled. Also very important to notice was the presence of osteocytes since, besides being the most common cells in bone tissue, these cells are believed to be the main regulators of bone homeostasis. [35] [36] [37] Common approaches in bone TE include the use of osteoblasts or stem cell-derived osteoblasts, a scaffold as a 3D matrix, and growth factors. 1, 4, 5 Scaffolds intend to support cell attachment and growth, and matrix production besides supplying mechanical resistance, considered extremely important for bone regeneration applications. 1, 4, 5 Its use presents, however, problems related to cell migration to the interior of the scaffold as well as oxygen and nutrient diffusion limitations, [7] [8] [9] [10] impairing such strategies to achieve more successful outcomes. The gold standard in clinical settings continues to be the autologous bone grafts. 4, 5 This technique causes nonetheless severe donor-site morbidity 4, 5 and allogenic or xenogenic grafts have even more obvious limitations. 4, 5 CS engineering is a technique that if applied to bone regeneration can overcome many of the current limitations of those approaches.
Previous works that used osteogenic CSs in in vivo settings, [18] [19] [20] either with or without scaffolds, have successfully induced the formation of new bone tissue. However, the newly formed tissue was in most cases either disorganized 18 or incapable of growing in the interior of the scaffold 19, 20 due to the already described scaffold limitations. CS engineering avoids all of these shortcomings although, the lack of mechanical properties or the time span needed for the formation of an adequate bone volume might be considered as limitative. The most obvious application for osteogenic CSs would be flat bone defects such as cranial defects. The shape of the CSs and the possibility of stacking several sheets, as shown for other tissues, 38, 39 would allow a fast transplantation to such a defect. Further, the mechanical requirements of flat bones are less demanding than that of long bones, 40 which avoids one of the possible limitation of CS engineering for bone regeneration. Nevertheless, in a recent article 41 reserchers applied a CS recovered by cell scraper in a rat nonunion model by wrapping the sheet around the defect. This resulted in the regeneration of the defect in opposition to the group without CS. This work presents a possible way by which CSs can be applied to the regeneration of long bones. In this case the CSs were recovered using a cell scraper, and although cell-cell junctions are preserved using this method, the use of thermoresponsive dishes guarantees that both cell-matrix junctions and the ECM itself are preserved. 12, 13 The ECM can then act as natural glue that enables these sheets to be applied virtually in any anatomic site when implanted. Maeda et al. 42 recently developed a device that allows a minimally invasive endoscopic transplantation of CSs fabricated in thermoresponsive dishes. Further developments of this method coupled with the attachment potential of the ECM open the way to deliver CSs, using a minimally invasive surgery, as de facto sheets for many applications, in opposition to the hypothesis of just injecting them, as suggested by other. 18, 41 Also, adequate bone volume can potentially be created by methods such as the overlay of several CSs combined with polysurgery, 38 creating thicker and bigger bone tissue. This specific issue will be addressed in future studies.
Conclusions
As already demonstrated for other tissues, CS engineering is also a very promising technique for bone TE applications. This work demonstrated that new bone tissue, with very interesting characteristics, namely, the presence of osteocytes, vascularization, and bone marrow formation, was formed from a single osteogenic CS. Three-dimensional neobone tissue was obtained in vivo without the use of any biodegradable scaffold and a new window of opportunity with great potential is open in the bone TE field. 
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